| Immediate hypersensitivity to polyethylene glycols and polysorbates: more common than we have recognized CA Stone Jr, Y Liu, MV Relling, MS Krantz, AL Pratt, A Abreo, JA Hemler, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (5), 1533-1540. e8, 2019 | 358 | 2019 |
| Safety evaluation of the second dose of messenger RNA COVID-19 vaccines in patients with immediate reactions to the first dose MS Krantz, JH Kwah, CA Stone, EJ Phillips, G Ortega, A Banerji, ... JAMA Internal Medicine 181 (11), 1530-1533, 2021 | 104 | 2021 |
| Risk of second allergic reaction to SARS-CoV-2 vaccines: a systematic review and meta-analysis DK Chu, EM Abrams, DBK Golden, KG Blumenthal, AR Wolfson, ... JAMA internal medicine 182 (4), 376-385, 2022 | 78 | 2022 |
| Emerging causes of drug-induced anaphylaxis: a review of anaphylaxis-associated reports in the FDA Adverse Event Reporting System (FAERS) JY Roger, MS Krantz, EJ Phillips, CA Stone Jr The Journal of Allergy and Clinical Immunology: In Practice 9 (2), 819-829. e2, 2021 | 68 | 2021 |
| Anaphylaxis to the first dose of mRNA SARS‐CoV‐2 vaccines: don't give up on the second dose! MS Krantz, MA Bruusgaard‐Mouritsen, G Koo, EJ Phillips, CA Stone Jr, ... Allergy 76 (9), 2916, 2021 | 64 | 2021 |
| Small ubiquitin‐like modifier 1–3 is activated in human astrocytic brain tumors and is required for glioblastoma cell survival W Yang, L Wang, G Roehn, RD Pearlstein, F Ali‐Osman, H Pan, ... Cancer science 104 (1), 70-77, 2013 | 60 | 2013 |
| Hidden dangers: recognizing excipients as potential causes of drug and vaccine hypersensitivity reactions ML Caballero, MS Krantz, S Quirce, EJ Phillips, CA Stone Jr The Journal of Allergy and Clinical Immunology: In Practice 9 (8), 2968-2982, 2021 | 56 | 2021 |
| Anaphylaxis to PEGylated liposomal echocardiogram contrast in a patient with IgE-mediated macrogol allergy MS Krantz, Y Liu, EJ Phillips, CA Stone The Journal of Allergy and Clinical Immunology: In Practice 8 (4), 1416-1419. e3, 2020 | 44 | 2020 |
| Oral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy MS Krantz, CA Stone, A Abreo, EJ Phillips The Journal of Allergy and Clinical Immunology: In Practice 8 (2), 757-760, 2019 | 39 | 2019 |
| COVID-19 vaccine anaphylaxis: PEG or not? MS Krantz, Y Liu, EJ Phillips, CA Stone Jr Allergy 76 (6), 1934-1937, 2021 | 27 | 2021 |
| Updates on the immunopathology and genomics of severe cutaneous adverse drug reactions A Gibson, P Deshpande, CN Campbell, MS Krantz, E Mukherjee, ... Journal of allergy and clinical immunology 151 (2), 289-300. e4, 2023 | 21 | 2023 |
| Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID‐19 vaccines: a systematic review and meta‐analysis M Greenhawt, M Shaker, DBK Golden, EM Abrams, KG Blumenthal, ... Allergy 78 (1), 71-83, 2023 | 15 | 2023 |
| Janssen COVID-19 vaccine tolerated in 10 patients with confirmed polyethylene glycol allergy MA Bruusgaard-Mouritsen, G Koo, AS Heinrichsen, BB Melchiors, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (3), 859-862, 2022 | 12 | 2022 |
| Criteria for intradermal skin testing and oral challenge in patients labeled as fluoroquinolone allergic MS Krantz, CA Stone Jr, R Yu, SN Adams, EJ Phillips The Journal of Allergy and Clinical Immunology: In Practice 9 (2), 1024-1028. e3, 2021 | 12 | 2021 |
| An academic hospital experience screening mRNA COVID-19 vaccine risk using patient allergy history MS Krantz, CA Stone, LA Rolando, AE Nobis, G Koo, KB Corey, ... The Journal of Allergy and Clinical Immunology: In Practice 9 (10), 3807-3810, 2021 | 8 | 2021 |
| Anaphylaxis to excipients in current clinical practice: evaluation and management MA Bruusgaard-Mouritsen, S Nasser, LH Garvey, MS Krantz, CA Stone Immunology and Allergy Clinics 42 (2), 239-267, 2022 | 6 | 2022 |
| The effect of delayed and early diagnosis in siblings, and importance of newborn screening for SCID MS Krantz, CA Stone, JA Connelly, AE Norton, YW Khan Annals of Allergy, Asthma & Immunology 122 (2), 211-213, 2019 | 6 | 2019 |
| Crowdsourcing to Define the Clinical Actionability of Incidental Findings of Genetic Testing MS Krantz, JS Berg North Carolina medical journal 74 (6), 501-502, 2013 | 5 | 2013 |
| COVID-19 mRNA vaccine safety during the first 6 months of roll-out in the USA MS Krantz, EJ Phillips The Lancet Infectious Diseases 22 (6), 747-748, 2022 | 4 | 2022 |
| Oral challenge with trimethoprim-sulfamethoxazole in patients with “sulfa” antibiotic allergy referred to an outpatient drug allergy clinic MS Krantz, CA Stone, A Abreo, EJ Phillips Journal of Allergy and Clinical Immunology 143 (2), AB209, 2019 | 4 | 2019 |
Cosby StoneAssistant Professor, Center for Drug Safety and Immunology, Vanderbilt University Medical CenterVerified email at vumc.org
